[Lambda in Business Wire] Iambic taps Lambda for increased AI compute as it develops the next generation of enchant, a breakthrough AI molecular property prediction model for drug discovery

SAN JOSE, Calif.–(BUSINESS WIRE)–Lambda, the GPU cloud company founded by AI engineers, today announced that Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, has selected Lambda to provide an NVIDIA HGX B200 cluster to support the training of Enchant, its industry-leading model for molecular property prediction.